Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Work In Process: 2024-2025

Historic Work In Process for Syndax Pharmaceuticals (SNDX) over the last 1 years, with Sep 2025 value amounting to $1.4 million.

  • Syndax Pharmaceuticals' Work In Process was N/A to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $330,000 for FY2024, which is N/A change from last year.
  • Per Syndax Pharmaceuticals' latest filing, its Work In Process stood at $1.4 million for Q3 2025, which was up 8.24% from $1.3 million recorded in Q2 2025.
  • Syndax Pharmaceuticals' 5-year Work In Process high stood at $1.4 million for Q3 2025, and its period low was $330,000 during Q4 2024.
  • Moreover, its 2-year median value for Work In Process was $923,500 (2025), whereas its average is $889,250.